EcoR1 Capital LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
EcoR1 Capital LLC | 4,288,120 4.800% |
132,745 (+3.19%) |
Filing |
| 2024-03-11 3:34 pm Purchase |
2024-02-28 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
EcoR1 Capital LLC | 4,155,375 5.300% |
4,155,375 (New Position) |
Filing |